McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. (July 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". Annals of Neurology. 50 (1): 121–127. CiteSeerX10.1.1.466.5368. doi:10.1002/ana.1032. PMID11456302. S2CID13870943.
Ntranos A, Lublin F (October 2016). "Diagnostic Criteria, Classification and Treatment Goals in Multiple Sclerosis: The Chronicles of Time and Space". Current Neurology and Neuroscience Reports. 16 (10): 90. doi:10.1007/s11910-016-0688-8. PMID27549391. S2CID4498332.
Chong HT, Kira J, Tsai CP, Ong B, Li PC, Kermode A, et al. (July 2009). "Proposed modifications to the McDonald criteria for use in Asia". Multiple Sclerosis. 15 (7): 887–888. doi:10.1177/1352458509104587. PMID19542266. S2CID46674042.
Fortini AS, Sanders EL, Weinshenker BG, Katzmann JA (November 2003). "Cerebrospinal fluid oligoclonal bands in the diagnosis of multiple sclerosis. Isoelectric focusing with IgG immunoblotting compared with high-resolution agarose gel electrophoresis and cerebrospinal fluid IgG index". American Journal of Clinical Pathology. 120 (5): 672–675. doi:10.1309/Y5VFF2UAW0RK5W63. PMID14608891.
Runia TF, Jafari N, Hintzen RQ (December 2013). "Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes". European Journal of Neurology. 20 (12): 1510–1516. doi:10.1111/ene.12243. PMID23906114. S2CID9493448.
Gaetani L, Prosperini L, Mancini A, Eusebi P, Cerri MC, Pozzilli C, et al. (November 2018). "2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes". Journal of Neurology. 265 (11): 2684–2687. doi:10.1007/s00415-018-9048-8. PMID30196327. S2CID52176296.
Awad A, Hemmer B, Hartung HP, Kieseier B, Bennett JL, Stuve O (February 2010). "Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis". Journal of Neuroimmunology. 219 (1–2): 1–7. doi:10.1016/j.jneuroim.2009.09.002. PMID19782408. S2CID206273704.
Brettschneider J, Jaskowski TD, Tumani H, Abdul S, Husebye D, Seraj H, et al. (December 2009). "Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases". Journal of Neuroimmunology. 217 (1–2): 95–101. doi:10.1016/j.jneuroim.2009.07.017. PMID19879655. S2CID43615028.
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. (July 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". Annals of Neurology. 50 (1): 121–127. CiteSeerX10.1.1.466.5368. doi:10.1002/ana.1032. PMID11456302. S2CID13870943.
Ntranos A, Lublin F (October 2016). "Diagnostic Criteria, Classification and Treatment Goals in Multiple Sclerosis: The Chronicles of Time and Space". Current Neurology and Neuroscience Reports. 16 (10): 90. doi:10.1007/s11910-016-0688-8. PMID27549391. S2CID4498332.
Chong HT, Kira J, Tsai CP, Ong B, Li PC, Kermode A, et al. (July 2009). "Proposed modifications to the McDonald criteria for use in Asia". Multiple Sclerosis. 15 (7): 887–888. doi:10.1177/1352458509104587. PMID19542266. S2CID46674042.
Fortini AS, Sanders EL, Weinshenker BG, Katzmann JA (November 2003). "Cerebrospinal fluid oligoclonal bands in the diagnosis of multiple sclerosis. Isoelectric focusing with IgG immunoblotting compared with high-resolution agarose gel electrophoresis and cerebrospinal fluid IgG index". American Journal of Clinical Pathology. 120 (5): 672–675. doi:10.1309/Y5VFF2UAW0RK5W63. PMID14608891.
Runia TF, Jafari N, Hintzen RQ (December 2013). "Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes". European Journal of Neurology. 20 (12): 1510–1516. doi:10.1111/ene.12243. PMID23906114. S2CID9493448.
Gaetani L, Prosperini L, Mancini A, Eusebi P, Cerri MC, Pozzilli C, et al. (November 2018). "2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes". Journal of Neurology. 265 (11): 2684–2687. doi:10.1007/s00415-018-9048-8. PMID30196327. S2CID52176296.
Awad A, Hemmer B, Hartung HP, Kieseier B, Bennett JL, Stuve O (February 2010). "Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis". Journal of Neuroimmunology. 219 (1–2): 1–7. doi:10.1016/j.jneuroim.2009.09.002. PMID19782408. S2CID206273704.
Brettschneider J, Jaskowski TD, Tumani H, Abdul S, Husebye D, Seraj H, et al. (December 2009). "Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases". Journal of Neuroimmunology. 217 (1–2): 95–101. doi:10.1016/j.jneuroim.2009.07.017. PMID19879655. S2CID43615028.
Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. (December 2005). "Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"". Annals of Neurology. 58 (6): 840–846. CiteSeerX10.1.1.604.2677. doi:10.1002/ana.20703. PMID16283615. S2CID54512368.
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. (July 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". Annals of Neurology. 50 (1): 121–127. CiteSeerX10.1.1.466.5368. doi:10.1002/ana.1032. PMID11456302. S2CID13870943.
semanticscholar.org
api.semanticscholar.org
Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. (December 2005). "Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"". Annals of Neurology. 58 (6): 840–846. CiteSeerX10.1.1.604.2677. doi:10.1002/ana.20703. PMID16283615. S2CID54512368.
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. (July 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". Annals of Neurology. 50 (1): 121–127. CiteSeerX10.1.1.466.5368. doi:10.1002/ana.1032. PMID11456302. S2CID13870943.
Ntranos A, Lublin F (October 2016). "Diagnostic Criteria, Classification and Treatment Goals in Multiple Sclerosis: The Chronicles of Time and Space". Current Neurology and Neuroscience Reports. 16 (10): 90. doi:10.1007/s11910-016-0688-8. PMID27549391. S2CID4498332.
Chong HT, Kira J, Tsai CP, Ong B, Li PC, Kermode A, et al. (July 2009). "Proposed modifications to the McDonald criteria for use in Asia". Multiple Sclerosis. 15 (7): 887–888. doi:10.1177/1352458509104587. PMID19542266. S2CID46674042.
Runia TF, Jafari N, Hintzen RQ (December 2013). "Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes". European Journal of Neurology. 20 (12): 1510–1516. doi:10.1111/ene.12243. PMID23906114. S2CID9493448.
Gaetani L, Prosperini L, Mancini A, Eusebi P, Cerri MC, Pozzilli C, et al. (November 2018). "2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes". Journal of Neurology. 265 (11): 2684–2687. doi:10.1007/s00415-018-9048-8. PMID30196327. S2CID52176296.
Awad A, Hemmer B, Hartung HP, Kieseier B, Bennett JL, Stuve O (February 2010). "Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis". Journal of Neuroimmunology. 219 (1–2): 1–7. doi:10.1016/j.jneuroim.2009.09.002. PMID19782408. S2CID206273704.
Brettschneider J, Jaskowski TD, Tumani H, Abdul S, Husebye D, Seraj H, et al. (December 2009). "Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases". Journal of Neuroimmunology. 217 (1–2): 95–101. doi:10.1016/j.jneuroim.2009.07.017. PMID19879655. S2CID43615028.
